CSPC Pharmaceutical Ownership
| CHJTF Stock | USD 0.67 0.16 19.28% |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
CSPC |
CSPC Pink Sheet Ownership Analysis
About 30.0% of the company shares are held by company insiders. The book value of CSPC Pharmaceutical was currently reported as 2.35. The company has Price/Earnings To Growth (PEG) ratio of 2.55. CSPC Pharmaceutical last dividend was issued on the 8th of September 2022. The entity had 6:5 split on the 18th of June 2020. CSPC Pharmaceutical Group Limited, an investment holding company, engages in the research and development, manufacture, and sale of pharmaceutical products in the Peoples Republic of China, other Asian regions, the Americas, Europe, and internationally. CSPC Pharmaceutical Group Limited was incorporated in 1992 and is headquartered in Shijiazhuang, the Peoples Republic of China. Cspc Pharmaceuticals operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange. It employs 25147 people.The quote for CSPC Pharmaceutical Group is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more info on CSPC Pharmaceutical Group please contact Dongchen Cai at 86 31 1870 37015 or go to https://www.cspc.com.hk.CSPC Pharmaceutical Outstanding Bonds
CSPC Pharmaceutical issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. CSPC Pharmaceutical uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most CSPC bonds can be classified according to their maturity, which is the date when CSPC Pharmaceutical Group has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View |
Currently Active Assets on Macroaxis
Other Information on Investing in CSPC Pink Sheet
CSPC Pharmaceutical financial ratios help investors to determine whether CSPC Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in CSPC with respect to the benefits of owning CSPC Pharmaceutical security.